FDA Import Refusal 799-5393798-1/11/1 — Natco Pharma,
The FDA refused shipment 799-5393798-1/11/1 from Natco Pharma, (India) on May 29, 2018. The refused product falls under Drugs and Biologics — IMATINIB MESYLATE (IMMUNOSUPPRESSIVE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 29, 2018
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 64TCY09 IMATINIB MESYLATE (IMMUNOSUPPRESSIVE)
- Charges
- 75